InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system, today announced that data from the Phase 3 study of vilobelimab ...
Zacks Small Cap Research on MSN
MDAI: DeepView Awarded $32 Million From BARDA
By John Vandermosten, CFA NASDAQ: MDAI READ THE FULL DYAI RESEARCH REPORT Spectral AI, Inc. (NASDAQ: MDAI) reported 2025 results on March 24th after the market close. Highlights since the company’s ...
USA Rare Earth, Inc. (Nasdaq: USAR) (the Company), an emerging global leader in rare earths, today announced its financial and operational results for the fourth quarter and year ended December 31, ...
USA Rare Earth, Inc. (Nasdaq: USAR) (the Company), an emerging global leader in rare earths, today announced its financial and operational results ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results